Tauroursodeoxycholic Acid
Product Description
Dipharma
-
IT
-
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
Categories
Specifications
Dipharma
-
IT
-
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from Dipharma (40)
-
Product Nortriptyline Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Nortriptyline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information. -
Product Pirfenidone
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Pirfenidone. It belongs to new products category. Therapeutic category: Immunosuppressant. Contact us for more information. -
Product Piroxicam
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Piroxicam. It belongs to commercial products category. Therapeutic category: Anti-inflammatory. Contact us for more information. -
Product Rufinamide
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Rufinamide. It belongs to new products category.
Therapeutic category: Anticonvulsant.
Contact us for more information. -
Product Selegiline Base*
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Selegiline Base*. It belongs to new products category. Therapeutic category: Antidepressant, Antiparkinson. Contact us for more information.
* only for specific markets. See our website -
Product Selegiline Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Selegiline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antiparkinsonian. Contact us for more information. -
Product Tolbutamide
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Tolbutamide. It belongs to commercial products category. Therapeutic category: Antidiabetic. Contact us for more information. -
Product Triamterene
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Triamterene. It belongs to commercial products category. Therapeutic category: Diuretic. Contact us for more information. -
Product Varenicline Tartrate
Dipharma manufactures wide range of active pharmaceutical ingredients including Varenicline Tartrate, a smoking-cessation product, which is nitrosamine free due to the dedicated process developed. Contact us for more information.
-
Product Ursodeoxycholic Acid
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Ursodeoxycholic Acid. It belongs to commercial products category. Therapeutic category: Cholelitholytic Agent. Contact us for more information. -
Product Vortioxetine HBr
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Vortioxetine HBr. It belongs to new products category. Therapeutic category: Antidepressant. Contact us for more information. -
Product Zonisamide
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Zonisamide. It belongs to commercial products category. Therapeutic category: Anticonvulsant. Contact us for more information.
Dipharma resources (4)
-
News Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process. The Company expands its range of CGMP services to include small-scale commercial APIs. -
Video Development and Manufacturing of New APIs: Leveraging Experience, Technological Innovation, and Present Vision to Future Success.
In today’s globalized economy, international integration plays a crucial role in the development of new molecules. This integration encompasses various aspects, including the transfer of production activities and the utilization of past experiences. Risk and Innovation: The development of APIs (active pharmaceutical ingredients) utilizes innovative process techniques and potentially hazardous chemical reactions. Leveraging past experiences is essential to mitigate risks and optimize production. Solid-State Development: A deep understanding of solid-state properties is critical for API manufacturers. Solid-state characterization ensures product stability, bioavailability, and manufacturability. -
News Dipharma expands its Italian R&D Center to increase its analytical services
The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.
-
Video The Dipharma Group - Experience you can trust
The Dipharma Group is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, offering APIs with DMFs registered worldwide.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance